Morgan Stanley’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.8K | Buy |
33,573
+26,188
| +355% | +$48.2K | ﹤0.01% | 6290 |
|
|
2025
Q1 | $10.6K | Sell |
7,385
-5,145
| -41% | -$7.41K | ﹤0.01% | 6781 |
|
|
2024
Q4 | $40K | Buy |
12,530
+12,426
| +11,948% | +$39.6K | ﹤0.01% | 6359 |
|
|
2024
Q3 | $713 | Sell |
104
-2,914
| -97% | -$20K | ﹤0.01% | 7270 |
|
|
2024
Q2 | $9.96K | Buy |
3,018
+1,810
| +150% | +$5.97K | ﹤0.01% | 6685 |
|
|
2024
Q1 | $5.02K | Sell |
1,208
-12,537
| -91% | -$52.1K | ﹤0.01% | 6887 |
|
|
2023
Q4 | $75K | Buy |
13,745
+12,076
| +724% | +$65.9K | ﹤0.01% | 6250 |
|
|
2023
Q3 | $12.4K | Buy |
1,669
+627
| +60% | +$4.67K | ﹤0.01% | 6654 |
|
|
2023
Q2 | $37.4K | Sell |
1,042
-93
| -8% | -$3.34K | ﹤0.01% | 6326 |
|
|
2023
Q1 | $87.1K | Buy |
1,135
+131
| +13% | +$10.1K | ﹤0.01% | 6069 |
|
|
2022
Q4 | $90.4K | Sell |
1,004
-49
| -5% | -$4.41K | ﹤0.01% | 6023 |
|
|
2022
Q3 | $59K | Sell |
1,053
-34
| -3% | -$1.91K | ﹤0.01% | 6333 |
|
|
2022
Q2 | $127K | Buy |
1,087
+169
| +18% | +$19.7K | ﹤0.01% | 6145 |
|
|
2022
Q1 | $263K | Buy |
918
+25
| +3% | +$7.16K | ﹤0.01% | 5777 |
|
|
2021
Q4 | $293K | Sell |
893
-21
| -2% | -$6.89K | ﹤0.01% | 5859 |
|
|
2021
Q3 | $459K | Sell |
914
-109
| -11% | -$54.7K | ﹤0.01% | 5551 |
|
|
2021
Q2 | $560K | Sell |
1,023
-8
| -0.8% | -$4.38K | ﹤0.01% | 5459 |
|
|
2021
Q1 | $636K | Buy |
1,031
+129
| +14% | +$79.6K | ﹤0.01% | 5021 |
|
|
2020
Q4 | $505K | Buy |
902
+179
| +25% | +$100K | ﹤0.01% | 5075 |
|
|
2020
Q3 | $459K | Buy |
723
+108
| +18% | +$68.6K | ﹤0.01% | 4692 |
|
|
2020
Q2 | $530K | Buy |
615
+184
| +43% | +$159K | ﹤0.01% | 4567 |
|
|
2020
Q1 | $269K | Buy |
431
+85
| +25% | +$53.1K | ﹤0.01% | 4739 |
|
|
2019
Q4 | $360K | Buy |
346
+256
| +284% | +$266K | ﹤0.01% | 5111 |
|
|
2019
Q3 | $78K | Buy |
90
+8
| +10% | +$6.93K | ﹤0.01% | 5531 |
|
|
2019
Q2 | $109K | Buy |
82
+47
| +134% | +$62.5K | ﹤0.01% | 5283 |
|
|
2019
Q1 | $52K | Sell |
35
-60
| -63% | -$89.1K | ﹤0.01% | 5649 |
|
|
2018
Q4 | $117K | Sell |
95
-635
| -87% | -$782K | ﹤0.01% | 5494 |
|
|
2018
Q3 | $1.78M | Sell |
730
-523
| -42% | -$1.28M | ﹤0.01% | 4089 |
|
|
2018
Q2 | $2.69M | Buy |
1,253
+125
| +11% | +$268K | ﹤0.01% | 3803 |
|
|
2018
Q1 | $1.13M | Buy |
1,128
+199
| +21% | +$200K | ﹤0.01% | 4457 |
|
|
2017
Q4 | $1.53M | Buy |
929
+255
| +38% | +$421K | ﹤0.01% | 4254 |
|
|
2017
Q3 | $1.11M | Buy |
674
+141
| +26% | +$232K | ﹤0.01% | 4351 |
|
|
2017
Q2 | $596K | Buy |
533
+221
| +71% | +$247K | ﹤0.01% | 4688 |
|
|
2017
Q1 | $274K | Buy |
312
+80
| +34% | +$70.3K | ﹤0.01% | 5164 |
|
|
2016
Q4 | $147K | Buy |
232
+179
| +338% | +$113K | ﹤0.01% | 5451 |
|
|
2016
Q3 | $43K | Buy |
53
+26
| +96% | +$21.1K | ﹤0.01% | 5648 |
|
|
2016
Q2 | $22K | Hold |
27
| – | – | ﹤0.01% | 5816 |
|
|
2016
Q1 | $24K | Sell |
27
-8
| -23% | -$7.11K | ﹤0.01% | 5865 |
|
|
2015
Q4 | $48K | Sell |
35
-2
| -5% | -$2.74K | ﹤0.01% | 5729 |
|
|
2015
Q3 | $50K | Hold |
37
| – | – | ﹤0.01% | 5730 |
|
|
2015
Q2 | $67K | Buy |
37
+4
| +12% | +$7.24K | ﹤0.01% | 5757 |
|
|
2015
Q1 | $56K | Sell |
33
-101
| -75% | -$171K | ﹤0.01% | 5753 |
|
|
2014
Q4 | $140K | Buy |
134
+56
| +72% | +$58.5K | ﹤0.01% | 5403 |
|
|
2014
Q3 | $120K | Buy |
78
+60
| +333% | +$92.3K | ﹤0.01% | 5389 |
|
|
2014
Q2 | $32K | Hold |
18
| – | – | ﹤0.01% | 5902 |
|
|
2014
Q1 | $38K | Buy |
+18
| New | +$38K | ﹤0.01% | 5804 |
|